Vasculopathy and insulin resistance in the JCR:LA-cp rat.
The JCR:LA-cp rat is one of a number of strains incorporating the autosomal recessive cp gene that induces obesity. This strain is unique in the development of not only a profound insulin resistance, but an accompanying cardiovascular disease that correlates strongly with hyperinsulinemia. The hyperinsulinemia develops rapidly after 4 weeks of age, with an age at half-maximum of 5.5 weeks. This reflects postprandial plasma insulin levels that peak at 1000 mU/l in a standardized meal tolerance test. Defective acetylcholine-mediated vascular relaxation develops with a 1-week lag over the developing hyperinsulinemia. The frequency of staining for the vascular adhesion molecules, VCAM-1 and ICAM, does not show either age or genotype variation, although plasma levels do show an age variation. Treatment of the rats with the alpha-glucosidase inhibitor, miglitol (Bay m1099), obviates the exaggerated postprandial glucose and, especially, the insulin responses of the cp/cp rat. This causes an improvement in insulin sensitivity, prevention of the impaired vascular relaxation, and reduction in plasma levels of advanced glycated end-products. Arterial wall morphology, as visualized by both scanning and transmission electron microscopy, shows abnormal endothelium, adherent macrophages, and activated migrating smooth muscle cells in the intima. Oil-Red-O staining reveals lipid deposits in the intimal spaces, as confirmed by the presence of foam cells. The lesions resemble fatty streaks or modest atherosclerosis in man, rather than the extensive cholesterol-laden lesions seen in familial hypercholesterolemia or cholesterol-fed rabbit models. The lean rats of the strain show similar, but less marked, intimal abnormalities. The vasculopathy in this animal model appears to be precipitated by the developing hyperinsulinemia, but also requires an underlying abnormality of vascular smooth muscle and possibly also of the endothelium.
Department of Pathology, McMaster University, Hamilton, Ontario, Canada.
M
M
Richardson
A M
AM
Schmidt
S E
SE
Graham
B
B
Achen
M
M
DeReske
J C
JC
Russell
D000818:Animals; D001158:Arteries / Q000648:ultrastructure; D017127:Glycation End Products, Advanced / Q000378:metabolism; D006946:Hyperinsulinism / Q000235:genetics; D007333:Insulin Resistance; D008297:Male; D008854:Microscopy, Electron; D009765:Obesity / Q000235:genetics; D051381:Rats; D011919:Rats, Inbred Strains / Q000235:genetics; D019010:Vascular Cell Adhesion Molecule-1 / Q000378:metabolism; D014652:Vascular Diseases / Q000235:genetics / Q000503:physiopathology*; D014664:Vasodilation / Q000502:physiology
D017127:Glycation End Products, Advanced; D019010:Vascular Cell Adhesion Molecule-1